Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Roy Davis, Peter Maag

Premium

Nanosphere has appointed Roy Davis to its board of directors. Davis worked for Johnson & Johnson for nearly three decades before he retired this January. Davis was president of J&J Development Corporation and VP of corporate development for the whole company.


XDx has named Peter Maag to be its president and CEO, effective immediately. Maag previously was president of Novartis Diagnostics, where he ran the company's blood screening business and created a strategy for the company's investment into developing diagnostics for transplantation, infectious disease, and prenatal care. He also was country president for Novartis Pharma in Germany and held other positions at Novartis after working at McKinsey and Company.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.